Bajaj HealthCare Limited (BAJAJHCARE.NS)
INR 569.3
(-4.08%)
INR 569.3
(-4.08%)
| Year | Total Debt | Total Debt Growth |
|---|---|---|
| 2023 | 3.32 Billion INR | -19.85% |
| 2022 | 4.15 Billion INR | 61.74% |
| 2021 | 2.56 Billion INR | 41.93% |
| 2020 | 1.8 Billion INR | 98.94% |
| 2019 | 909.25 Million INR | 12.63% |
| 2018 | 807.26 Million INR | -6.69% |
| 2017 | 865.15 Million INR | 15.4% |
| 2016 | 749.7 Million INR | -7.7% |
| 2015 | 812.25 Million INR | 36.19% |
| 2014 | 596.41 Million INR | -5.5% |
| 2013 | 631.12 Million INR | -0.85% |
| 2012 | 636.52 Million INR | 20.36% |
| 2011 | 528.86 Million INR | 27.19% |
| 2010 | 415.82 Million INR | 0.0% |
| Year | Total Debt | Total Debt Growth |
|---|---|---|
| 2024 Q1 | - INR | -100.0% |
| 2023 Q4 | 3.32 Billion INR | 0.0% |
| 2023 FY | 3.32 Billion INR | -19.85% |
| 2023 Q1 | - INR | -100.0% |
| 2023 Q3 | - INR | -100.0% |
| 2023 Q2 | 3.56 Billion INR | 0.0% |
| 2022 Q2 | 3.34 Billion INR | 0.0% |
| 2022 Q1 | - INR | -100.0% |
| 2022 FY | 4.15 Billion INR | 61.74% |
| 2022 Q4 | 4.15 Billion INR | 0.0% |
| 2022 Q3 | - INR | -100.0% |
| 2021 FY | 2.56 Billion INR | 41.93% |
| 2021 Q3 | - INR | -100.0% |
| 2021 Q1 | - INR | -100.0% |
| 2021 Q2 | 2.11 Billion INR | 0.0% |
| 2021 Q4 | 2.56 Billion INR | 0.0% |
| 2020 Q2 | 1.11 Billion INR | 0.0% |
| 2020 Q4 | 1.8 Billion INR | 0.0% |
| 2020 FY | 1.8 Billion INR | 98.94% |
| 2020 Q1 | - INR | -100.0% |
| 2020 Q3 | - INR | -100.0% |
| 2019 Q2 | 750.02 Million INR | 0.0% |
| 2019 FY | 909.25 Million INR | 12.63% |
| 2019 Q4 | 909.25 Million INR | 0.0% |
| 2019 Q3 | - INR | -100.0% |
| 2019 Q1 | - INR | -100.0% |
| 2018 Q4 | 807.26 Million INR | 0.0% |
| 2018 Q2 | 861.18 Million INR | 0.0% |
| 2018 Q3 | 807.26 Million INR | -6.26% |
| 2018 FY | 807.26 Million INR | -6.69% |
| 2018 Q1 | 861.18 Million INR | -0.46% |
| 2017 Q1 | 689.52 Million INR | -8.03% |
| 2017 Q2 | 689.52 Million INR | 0.0% |
| 2017 Q3 | 865.15 Million INR | 25.47% |
| 2017 Q4 | 865.15 Million INR | 0.0% |
| 2017 FY | 865.15 Million INR | 15.4% |
| 2016 Q3 | 749.7 Million INR | 6.94% |
| 2016 Q2 | 701.06 Million INR | 0.0% |
| 2016 Q4 | 749.7 Million INR | 0.0% |
| 2016 FY | 749.7 Million INR | -7.7% |
| 2016 Q1 | 701.06 Million INR | -13.69% |
| 2015 Q2 | 743.63 Million INR | 0.0% |
| 2015 Q4 | 812.25 Million INR | 11.72% |
| 2015 Q3 | 727.05 Million INR | -2.23% |
| 2015 Q1 | 743.63 Million INR | 0.0% |
| 2015 FY | 812.25 Million INR | 36.19% |
| 2014 FY | 596.41 Million INR | -5.5% |
| 2013 FY | 631.12 Million INR | -0.85% |
| 2012 FY | 636.52 Million INR | 20.36% |
| 2011 FY | 528.86 Million INR | 27.19% |
| 2010 FY | 415.82 Million INR | 0.0% |
| Name | Total Debt | Total Debt Difference |
|---|---|---|
| Alembic Pharmaceuticals Limited | 5.13 Billion INR | 35.142% |
| Bafna Pharmaceuticals Limited | 243.89 Million INR | -1264.632% |
| FDC Limited | 205.18 Million INR | -1522.069% |
| Gufic Biosciences Limited | 3.32 Billion INR | 0.027% |
| Jubilant Pharmova Limited | 36.64 Billion INR | 90.916% |
| Nectar Lifesciences Limited | 6.35 Billion INR | 47.631% |
| Orchid Pharma Limited | 1.35 Billion INR | -146.207% |
| Alkem Laboratories Limited | 14.18 Billion INR | 76.535% |
| Brooks Laboratories Limited | 56.41 Million INR | -5799.153% |
| Eris Lifesciences Limited | 27.81 Billion INR | 88.033% |
| Glenmark Life Sciences Limited | 171.48 Million INR | -1840.893% |
| Solara Active Pharma Sciences Limited | 10.11 Billion INR | 67.096% |
| Innova Captab Limited | 2.45 Billion INR | -35.789% |
| Jagsonpal Pharmaceuticals Limited | 89.41 Million INR | -3622.451% |
| Wanbury Limited | 1.16 Billion INR | -185.724% |
| Lupin Limited | 29.21 Billion INR | 88.609% |
| Aarti Drugs Limited | 5.64 Billion INR | 41.017% |
| Aarti Pharmalabs Limited | 2.85 Billion INR | -16.678% |
| Albert David Limited | 33.24 Million INR | -9912.163% |
| Alembic Limited | 91.5 Million INR | -3537.424% |
| Biofil Chemicals and Pharmaceuticals Limited | 4.38 Million INR | -75731.465% |
| Hester Biosciences Limited | 2.44 Billion INR | -36.192% |
| Hikal Limited | 8.17 Billion INR | 59.292% |
| Ind-Swift Laboratories Limited | 166.21 Million INR | -1902.36% |
| Ind-Swift Limited | 10.13 Billion INR | 67.177% |
| IOL Chemicals and Pharmaceuticals Limited | 327.6 Million INR | -915.947% |
| Kilitch Drugs (India) Limited | 316.46 Million INR | -951.694% |
| Lincoln Pharmaceuticals Limited | 10.66 Million INR | -31098.378% |
| Mangalam Drugs & Organics Limited | 984.92 Million INR | -237.918% |
| Medico Remedies Limited | 80.5 Million INR | -4034.258% |
| Morepen Laboratories Limited | 289.99 Million INR | -1047.702% |
| Procter & Gamble Health Limited | 95.6 Million INR | -3381.426% |
| RPG Life Sciences Limited | - INR | -Infinity% |
| Sigachi Industries Limited | 1.43 Billion INR | -132.66% |
| Sun Pharmaceutical Industries Limited | 32.73 Billion INR | 89.833% |
| Suven Pharmaceuticals Limited | 649.96 Million INR | -412.066% |
| Themis Medicare Limited | 957.92 Million INR | -247.444% |
| Unichem Laboratories Limited | 2.47 Billion INR | -34.467% |
| Vaishali Pharma Limited | 134.91 Million INR | -2366.864% |
| Venus Remedies Limited | 413.3 Million INR | -705.285% |
| Windlas Biotech Limited | 36.41 Million INR | -9041.013% |
| ZIM Laboratories Limited | 1.08 Billion INR | -205.836% |
| Sakar Healthcare Limited | 793.51 Million INR | -319.43% |
| Aurobindo Pharma Limited | 66.47 Billion INR | 94.993% |
| Divi's Laboratories Limited | 30 Million INR | -10994.143% |
| AstraZeneca Pharma India Limited | 45.98 Million INR | -7138.143% |
| Mankind Pharma Limited | 2.07 Billion INR | -60.651% |
| Sequent Scientific Limited | 4.87 Billion INR | 31.755% |
| Laurus Labs Limited | 25.77 Billion INR | 87.087% |
| Neuland Laboratories Limited | 953.89 Million INR | -248.91% |
| J. B. Chemicals & Pharmaceuticals Limited | 3.77 Billion INR | 11.872% |
| Glenmark Pharmaceuticals Limited | 12.3 Billion INR | 72.962% |
| Zydus Lifesciences Limited | 8.04 Billion INR | 58.614% |
| Amrutanjan Health Care Limited | 17.28 Million INR | -19157.322% |
| Wockhardt Limited | 23.56 Billion INR | 85.873% |
| Bal Pharma Limited | 1.39 Billion INR | -138.33% |
| Dr. Reddy's Laboratories Limited | 20.02 Billion INR | 83.375% |
| Bliss GVS Pharma Limited | 998.4 Million INR | -233.357% |
| Par Drugs and Chemicals Limited | - INR | -Infinity% |
| Caplin Point Laboratories Limited | 19.7 Million INR | -16794.635% |
| Shilpa Medicare Limited | 9.37 Billion INR | 64.495% |
| Valiant Laboratories Limited | 767.08 Million INR | -333.882% |
| Ajanta Pharma Limited | 352.8 Million INR | -843.38% |
| Aarey Drugs & Pharmaceuticals Limited | 313.52 Million INR | -961.562% |
| Granules India Limited | 13.15 Billion INR | 74.691% |
| Medicamen Biotech Limited | 308.17 Million INR | -979.995% |
| Ipca Laboratories Limited | 14.38 Billion INR | 76.861% |
| Syncom Formulations (India) Limited | 724.86 Million INR | -359.153% |
| Piramal Enterprises Limited | 535.85 Billion INR | 99.379% |
| Torrent Pharmaceuticals Limited | 40.22 Billion INR | 91.725% |
| NATCO Pharma Limited | 3.71 Billion INR | 10.338% |
| Suven Life Sciences Limited | 7.09 Million INR | -46796.477% |
| Krebs Biochemicals & Industries Limited | 1.93 Billion INR | -72.065% |
| Strides Pharma Science Limited | 25.16 Billion INR | 86.776% |
| Indoco Remedies Limited | 6.71 Billion INR | 50.47% |
| Alpa Laboratories Limited | 52.46 Million INR | -6243.74% |
| Lasa Supergenerics Limited | 220.76 Million INR | -1407.616% |
| Sun Pharma Advanced Research Company Limited | 611.5 Million INR | -444.275% |